Overview
Status
Active
Registry date
2022-10-21
Share capital
5,000.00 PLN
Registered address
ul. Wschodnia 18, 22-170 Rejowiec Fabryczny, Poland
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 11 days early.
- 202513/07/2026
- 202416/06/2025
- 202313/07/2024
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 100.43kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 15.10kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 82.82kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 45.46kMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Monika Orzeł Pankowska – President of the Management Board
Manner of representation
Each member of the management board is independently entitled to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Monika Emilia Orzeł Pankowskaage 46 | 50 | $675.31 | 50% |
Robert Paweł Pankowskiage 47 | 50 | $675.31 | 50% |
Monika Emilia Orzeł Pankowska and Robert Paweł Pankowski hold a combined 100% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawexsp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| LubfarmS.A. | $123,208,945.21 | lubfarm.pl | ||
| Camedica Paweł Harasimiuksp. k. | $18,691,613.15 | camedica.pl | ||
| Medcomplexsp. z o.o. | $5,193,830.09 | medcomplex.pl | ||
| Przedsiębiorstwo Zaopatrzenia Lecznictwa Cezal Lublinsp. z o.o. | $4,277,670.93 | cezal.lublin.pl | ||
| Bio-Novumsp. z o.o. | $3,459,663.10 | bio-novum.com | ||
| Myderm Laboratoriessp. z o.o. | $177,750.48 | myderm.com.pl | ||
| GROW Pharmasp. z o.o. | $15,020.86 | growpharma.pl | ||
| PetnovellS.A. | $0.00 | petnovell.pl | ||
| Dental Łukasiksp. j. | – | dental.lublin.pl |
FAQ
The main business activity of BMT focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on October 21, 2022.
The headquarters is located at: ul. Wschodnia 18, 22-170 Rejowiec Fabryczny.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $88,936 in 2024, which is an increase of 45.8% compared to 2023.
Yes, the company recorded a net profit of $17,345 in 2024, meaning the company increased its profit by 204.7%.
The largest operating cost category falls under employee remuneration. This category amounted to $31,822 in 2024, representing 46% of all operating expenses.
Last updated: 2026-07-16
